Lumida
/CLPT
⌘K
Clearpoint Neuro Inc

Clearpoint Neuro Inc

CLPT
$13.72USD↑+1.78%+0.24 today

MARKET CAP

418.5M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$13 – $14

52W RANGE

$8
$30

AI Summary

Stalk
StalkMedium

CLPT remains in a Stage 2 advancing corrective reset with clear higher highs and higher lows. Price is currently extended above rising short-term EMAs and in extreme overbought territory, and the late-June bearish exhaustion candle signals waning upside momentum and a likely pullback. Under a Speculative strategy, high asymmetry and defined structure are required, so patience is advised. A pullback toward the 9/21 EMA zone offers a more favorable entry for continuation participation.

  • ↑Q2 revenue $10.9M (+18% YoY), signaling sustained product demand.
  • ↑New 30k ft² lab (CAL) to expand capacity, targeting >$60M rev.
  • ↓H1 operational cash burn of $15M reduced cash reserves to $29.4M.
Full analysis →

Buying

5

institutions

Selling

1

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

BUY2.38 M42.46 M+297.05 K+124.0%0.00%
MM

Millennium Management LLC

Q2 2026

BUY409.98 K7.31 M+178.00 K+246.5%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY222.79 K3.97 M+122.29 K+334.6%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL15.99 K310.65 K+-71.00+123.4%0.00%
MG

Man Group Plc

Q2 2026

BUYNEW11.95 K213.19 K+11.95 K+0.0%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

BUYNEW50.00892.00+50.00+0.0%0.00%